Anti-CD20 and mTOR inhibitors: Can we change the prognosis of post-transplant lymphoproliferative disorder?

Autor:	T. Cavero Escribano, M. Pamplona Casamayor, F. Guerrero Ramos, J.M. Duarte Ojeda, J. Medina Polo, E. González Monte, A. Rodríguez Antolín, F. De La Rosa Kehrmann, F. Villacampa Aubá, A. Tejido Sánchez, J. Passas Martínez
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty business.industry Urology Internal medicine medicine Anti cd20 medicine.disease business Discovery and development of mTOR inhibitors Post-transplant lymphoproliferative disorder
Zdroj:	European Urology Supplements. 17:e771
ISSN:	1569-9056
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f69be7343665622694d291dc002ff197 https://doi.org/10.1016/s1569-9056(18)31369-1 Zobrazit plný text záznamu Full Text from ScienceDirect